FTC Report Finds Decline In Potential Pay-For-Delay Deals
By Vin Gurrieri ( December 22, 2014, 5:48 PM EST) -- The U.S. Federal Trade Commission on Monday issued a report finding that the number of potentially anti-competitive patent settlements over the past fiscal year between branded pharmaceutical companies and generic-drug makers dropped significantly from the previous record high filed two years ago....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.